期刊文献+

血清蛋白与阳离子多糖的质量比对RNAi效率的调控作用研究

Relationship Between Serum and RNAi Efficiency
原文传递
导出
摘要 阳离子多糖可以通过静电相互作用与核酸分子相结合,并具有水溶性好和易被生物体降解的优点,是具有潜在临床应用价值的核酸载体.但是,在血清存在的环境中,阳离子多糖与si RNA形成的复合物会吸附血清蛋白,这是影响RNA干扰效率的主要原因之一.本文以精胺化普鲁兰多糖(Ps)作为阳离子多糖的模型材料,通过凝胶电泳、等温滴定量热、动态光散射和流式细胞分析方法研究了血清蛋白(Pr)与Ps的质量比(Pr/Ps)对Ps/si RNA复合物的颗粒尺寸及RNA干扰效率的影响.结果显示,Pr/Ps对复合物的颗粒尺寸及其进入细胞的能力均起着重要的调节作用,由此而影响RNA干扰的效率. Cationic polysaccharide is a promising si RNA carrier for its water-solubility, biodegradable character, and the binding ability with nucleic acid. However, the low RNA interference activity in serum containing conditions caused by the adsorption of serum protein is a big barrier for its clinic use. In this study, spermine modified pullulan(pullulan-spermine, Ps), a cationic polymer carrier, was used as a model material to study its hydrodynamic diameter, cell internalization character, and RNAi efficacy in different serum containing conditions. Results showed that the relative amount of protein and Ps could regulate the particle size of Ps/si RNA complex and finally affect the Ps mediated RNAi efficiency.
出处 《中国科学:生命科学》 CSCD 北大核心 2016年第6期744-750,共7页 Scientia Sinica(Vitae)
基金 国家自然科学基金(批准号:81271688)资助
关键词 RNAI 精胺化普鲁兰多糖 血清蛋白 RNAi pullulan-spermine serum protein
  • 相关文献

参考文献24

  • 1Dykxhoorn D M,Lieberman J.Knocking down Disease with siRNAs.Cell,2006,126:231-235.
  • 2卢晶,陈锋,徐珍,张灵灵,徐鹏,刘德培,梁植权.逆转录病毒载体表达的膜型免疫球蛋白介导B细胞受体细胞信号传导[J].中国科学:生命科学,2015,45(9):860-870. 被引量:1
  • 3Butz K,Ristriani T,Hengstermann A,et al.siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells.Oncogene,2003,22:5938-5945.
  • 4Thomas C E,Ehrhardt A,Kay M A.Progress and problems with the use of viral vectors for gene therapy.Nat Rev Genet,2003,4:346-358.
  • 5Gao Y,Liu X L,Li X R.Research progress on siRNA delivery with nonviralcarriers.Int J Nanomedicine,2011,6:1017-1025.
  • 6Howard K A.Delivery of RNA interference therapeutics using polycation-based nanoparticles.Advanced Drug Delivery Rev,2009,61:710-720.
  • 7Swierczewska M,Han H S,Kim K,et al.Polysaccharide-based nanoparticles for theranostic nanomedicine.Advanced Drug Delivery Rev,2016,99:70-84.
  • 8Singh D,Han S S,Shin E J.Polysaccharides as Nanocarriers for Therapeutic Applications.j biomed nanotechnol,2014,10:2149-2172.
  • 9Ahmed T A,Aljaeid B M.Preparation,characterization,and potential applicationof chitosan,chitosan derivatives,and chitosan metal nanoparticles inpharmaceutical drug delivery.Drug Des Devel Ther,2016,10:483-507.
  • 10Singh R S,Kaur N,Kennedy J F.Pullulan and pullulan derivatives as promising biomolecules for drug and gene targeting.Carbohydrate Polymers,2015,123:190-207.

二级参考文献19

  • 1Niiro H, Clark E A. Regulation of B-cell fate by antigen-receptor signals. Nat Rev Immunol, 2002, 2:945-956.
  • 2Reth M, Wienands J. Initiation and processing of signals from the B-cell antigen receptor. Annu Rev Immunol, 1997, 15:453-479.
  • 3Kurosaki T. Regulation of BCR signaling. Mol Immunol, 2011, 48:1287-1291.
  • 4Sanchez M, Misulovin Z, Burkhardt A L, et al. Signal transduction by immunoglobulin is mediated through Ig alpha and Ig beta. J Exp Med, 1993, 178:1049-1055.
  • 5Flaswinkel H, Reth M. Dual role of the tyrosine activation motif of the Ig-alpha protein during signal transduction via the B cell antigen receptor. EMBO, 1994, 13:83-89.
  • 6Glimcher L H, Kim K J, Green I, et al. Ia antigen-bearing B cell tumor lines can present protein antigen and alloantigen in a major histocompatibility complex-restricted fashion to antigen-reactive T cells. J Exp Med, 1982, 155:445-459.
  • 7Justemen L B, Campbell K S, Chien N C, et al. Regulation of B cell antigen receptor signal transdnction and phosphorylation by CD45. Science, 1991, 252:1839-1842.
  • 8Ru W, Peijie C. Modulation of NKT cells and Thl/Th2 imbalance after alpha-GalCer treatment in progressive load-trained rats. Int J Biol Sci, 2009, 5:338-343.
  • 9Andersson J, Moiler G, Sjoberg O. Selective induction of DNA synthesis in T and B lymphocytes. Cell Immunol, 1972, 4:381-393.
  • 10Blomgren H, Svedmyr E. Evidence for thymic dependence of PHA-reactive cells in spleen and lymph nodes and independence in bone marrow. J Immunol, 1971, 106:835-845.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部